NEW YORK (Reuters Health) – Dual anti-HER2 treatment with pertuzumab plus trastuzumab appears well tolerated and gives promising results in certain patients with HER2-positive advanced cancer of the biliary tract, according to an analysis of data from the MyPathway study….
Read More
Study shows safety and efficacy of radio-wave therapy for liver cancer patients
Researchers at Wake Forest School of Medicine have shown that a targeted therapy using non-thermal radio waves is safe to use in the treatment of hepatocellular carcinoma (HCC), the most common type of liver cancer. The therapy also showed a…
Read More
Exercise could be used to improve the oral environment in people with NAFLD
Liver disease, from metabolic and bacterial causes, is a growing concern. What connects these dots? The gut, or more specifically, bacteria in the gut. Bacteria that cause inflammation in the mouth are transported through the digestive tract to the gut…
Read More
CN Bio introduces the PhysioMimix™ OOC Multi-Organ Microphysiological System
CN Bio, a leading developer of single and multi-organ microphysiological systems (MPS), otherwise known as organ-on-a-chip (OOC), today announced the commercial launch of its new PhysioMimix™ OOC Multi-Organ MPS. The next-generation platform combines CN Bio’s in vitro 3D liver model,…
Read More
The Best Foods To Eat To Cleanse Your Liver
While the term “cleanse” may bring up thoughts of water fasting and other intense methods made to enhance your liver’s function, cleansing your liver is actually just supporting its natural processes. Since the foods you eat directly impact various organs…
Read More
Scientists identify cells responsible for liver tissue maintenance and regeneration
While the amazing regenerative power of the liver has been known since ancient times, the cells responsible for maintaining and replenishing the liver have remained a mystery. Now, research from the Children’s Medical Center Research Institute at UT Southwestern (CRI)…
Read More
Abacavir/Lamivudine 600/300 APOTEX
NOTICE: This Consumer Medicine Information (CMI) is intended for persons living in Australia. ABACAVIR/LAMIVUDINE 600/300 APOTEX TABLET Contains the active ingredients abacavir (as sulfate) and lamivudine Consumer Medicine Information PATIENTS TAKING ABACAVIR AND LAMIVUDINE COMBINATION TABLETS, WHICH CONTAINS ABACAVIR, MAY…
Read More
Zocor (MK)
NOTICE: This Consumer Medicine Information (CMI) is intended for persons living in Australia. ZOCOR® Simvastatin Consumer Medicine Information What is in this leaflet This leaflet answers some common questions about ZOCOR.It does not contain all the available information. It does…
Read More
Amlodipine/Valsartan/HCT Novartis
NOTICE: This Consumer Medicine Information (CMI) is intended for persons living in Australia. VALSARTAN/AMLODIPINE/HCT NOVARTIS® 5/160/12.5, 5/160/25, 10/160/12.5, 10/160/25, 10/320/25 amlodipine besilate/valsartan/hydrochlorothiazide Consumer Medicine Information What is in this leaflet This leaflet answers some common questions about AMLODIPINE/VALSARTAN/HCT NOVARTIS. It…
Read More
Tambocor
NOTICE: This Consumer Medicine Information (CMI) is intended for persons living in Australia. TAMBOCOR® (tam-bo-core) Flecainide acetate (fleck-ain-ide-ass-e-tate) Consumer Medicine Information What is in this leaflet This leaflet answers some common questions about Tambocor tablets. It does not contain all…
Read More